Drug gets priority review as CLL treatmentJanuary 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA approves rapid-infusion bendamustineDecember 11, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA grants KTE-C19 breakthrough designationDecember 10, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Cancer drug prices vary widely from country to countryDecember 7, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
FDA approves generic imatinibDecember 6, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
EC grants conditional approval for blinatumomabNovember 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALL
Trial of ofatumumab in FL stopped earlyNovember 25, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
CHMP recommends pegaspargase for ALLNovember 24, 2015Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL